Obese individuals with nonalcoholic steatohepatitis (NASH) were characterised by higher D6D and SCD1 activity and lower D5D activity compared to individuals with a normal liver. This evidence concerns the gene SCD and metabolic dysfunction-associated steatohepatitis.